Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-030308
Date:2022-05-17
Issuer: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Original Submission Date:

Reporting Person:

FRIDRIKSDOTTIR HAFRUN
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
124 DVORA HANEVI'A ST., TEL AVIV, L3 6944020

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2022-05-17 S 130,000 d $8.22 1,387 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $8.185 to$8.240, inclusive. the reporting person undertakes to provide, upon request by the sec staff, the issuer, or any security holder of the issuer,full information regarding the number of shares sold at each separate price.
f3 the shares held by the reporting person prior to the sale reported in this form 4 included 5,300 ordinary shares previously issued to the reporting person in exempt transactions in connection with the settlement of certain equity-based awards granted to the reporting person, which were inadvertently omitted from the reporting person's previously reported amount of securities beneficially owned.

Elevate your investments